
The New York venture capital firm Insight Venture Partners, and mutual fund company T. Rowe Price could join two existing Twitter backers, Spark Capital and Institutional Venture Partners, in a deal that would value the Internet company at $1 billion, according to sources.
Some suggest Twitter is close to a deal that would zip up a round of financing at roughly $100 million. And while it would give the company more than enough cash to comfortably build out its user base to about a billion, some industry insiders are more fascinated by the valuation than the round of funding.
Venture capitalists believe it's a bit of a guessing game when it comes to establishing a value for a company that has not previously earned revenue. It harkens back to the dot-com era, when executives believed that traffic signaled value. And if there's value, they can find a way to monetize it. With this in mind, some venture capitalists take the leap of faith.
The basis of all valuation is the discounted cash-flow analysis. It has two parts: cash flow for some period of time, and terminal value, explains Jordan Rohan, founder and managing partner at Clearmeadow Partners. "To value a company at more than $1 billion, in the absence of current cash flows, one would have to think you could sell the company for much more than $1 billion someday soon," he says.
VCs don't want to miss a potential opportunity. Industry executives believe few would view venture capitalists investing in Twitter as idiots because of the noise it has managed to generate -- for example, most cable and network TV newscasts and radio shows that reference Twitter during broadcasts. That's not to mention newspapers and magazine articles that include a Twitter feed. It's similar to free advertising.
"If that noise translates into the sound of cha-ching, you want to make sure you've hedged your bet as a venture investor so you don't miss the opportunity," says Michael Kassan, chairman and CEO at Media Link LLC.
by Laurie Sullivan, Yesterday, 6:21 PM
No comments:
Post a Comment